Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...
Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...
In May 2017, Outsourcing-Pharma.com conducted its inaugural “state of the industry” survey of its user base of pharmaceutical industry professionals, including...
Recipharm AB | 15-May-2017
| Technical / White Paper
Selecting and developing an appropriate dosage form for inhalation products can be challenging. The physicochemical properties of the API, the required...
A controlled document distribution process, in which getting the right information to the intended recipients within a required time frame and being able...
Marken maximizes efficiency and enhances service offerings while continuing to specialize in the high-touch, personalized services that the company is...
Catalent Pharma Solutions | 23-Jan-2017
| Technical / White Paper
Clinical trials are more complex than ever before, driving the industry to develop and adopt new ways to manage clinical supplies and address new challenges.Fast...
Regulatory control of elemental impurities in pharmaceutical products has long been discussed, with both the European Pharmacopeia (EP) and the United...
World Courier | 10-Oct-2016
| Technical / White Paper
Take your clinical trials to the next level. The direct-to-patient (DtP) model solves two of the largest issues plaguing clinical trials: patient recruitment...
Adaptive protocol designs, shrinking trial sizes and a growing focus on patients are just a few of the clinical trial trends and recent innovations that...
The data used to determine the success of a cleaning validation is built upon both the effective evaluation of the manufacturing plant and the robustness...
Butterworth | 26-May-2016
| Technical / White Paper
The International Conference of Harmonisation (ICH) guidance document on elemental impurities, Q3D, reached step 4 in December 2014, meaning the final...
B. Braun Melsungen AG | 10-May-2016
| Technical / White Paper
B. Braun OEM offers standard products or customized versions. Even the standard range contains hundreds of product versions, with which countless applications...
Baxter BioPharma Solutions | 09-May-2016
| Case Study
This case study provides an in-depth look at Baxter BioPharma Solutions’ latest expansion at their Halle, Germany cytotoxic facility, offering insight...
